ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

CLSI update annual AST review webinars

05 Feb 2014 10:00 AM | Christopher McCoy
Each January, CLSI updates standards for antimicrobial susceptibility testing (AST). It is important for clinical laboratories to incorporate the new recommendations into routine practice to optimize detection and reporting of antimicrobial resistance. As of January 2014, the annual update of the M100 tables (CLSI document M100-S24) has been published. Some highlights for 2014 include guidelines for testing cefazolin as a surrogate for oral agents that might be used for treating uncomplicated urinary tract infections and interpreting results for carbapenems and Acinetobacter spp. The revised breakpoints for cefepime and Enterobacteriaceae, including the new susceptible-dose dependent interpretive category will be explained. These changes and several other new recommendations found in M100-S24 will be discussed. In addition to the webinar, an optional post-program self-assessment will be held that will allow individuals to assess their knowledge regarding the most important AST and reporting issues for 2014.  To learn more and register visit here.


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software